We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBLY icon
1776
Mobileye
MBLY
$7.57B
$1.29M ﹤0.01%
40,086
-23,285
-37% -$661K
INMD icon
1777
InMode
INMD
$876M
$1.29M ﹤0.01%
59,610
+11,643
+24% +$260K
SLVM icon
1778
Sylvamo
SLVM
$1.53B
$1.29M ﹤0.01%
20,815
+1,338
+7% +$71.5K
XHR
1779
Xenia Hotels & Resorts
XHR
$1.73B
$1.29M ﹤0.01%
85,665
+2,888
+3% +$40.3K
DNB
1780
DELISTED
Dun & Bradstreet
DNB
$1.28M ﹤0.01%
127,708
+8,540
+7% +$93.2K
CNA icon
1781
CNA Financial
CNA
$13.7B
$1.28M ﹤0.01%
28,141
+1,618
+6% +$71.4K
DK icon
1782
Delek US
DK
$4.12B
$1.28M ﹤0.01%
41,605
+1,829
+5% +$49.5K
DOCN icon
1783
DigitalOcean
DOCN
$15.6B
$1.28M ﹤0.01%
33,457
+1,527
+5% +$56.7K
AVDX
1784
DELISTED
AvidXchange
AVDX
$1.28M ﹤0.01%
97,054
+5,563
+6% +$66.8K
ROG icon
1785
Rogers Corp
ROG
$2.48B
$1.27M ﹤0.01%
10,689
+613
+6% +$71.7K
DGRO icon
1786
iShares Core Dividend Growth ETF
DGRO
$43.9B
$1.27M ﹤0.01%
21,827
+12,905
+145% +$716K
MIR icon
1787
Mirion Technologies
MIR
$3.79B
$1.27M ﹤0.01%
111,519
+7,264
+7% +$72.8K
RLJ icon
1788
RLJ Lodging Trust
RLJ
$1.66B
$1.27M ﹤0.01%
107,116
+2,071
+2% +$24.4K
ABR icon
1789
Arbor Realty Trust
ABR
$974M
$1.26M ﹤0.01%
95,129
+6,697
+8% +$89.8K
FLG
1790
Flagstar Bank National Association
FLG
$5.9B
$1.26M ﹤0.01%
130,401
+5,906
+5% +$109K
BFH icon
1791
Bread Financial
BFH
$4.46B
$1.26M ﹤0.01%
33,782
+1,856
+6% +$65.9K
CDE icon
1792
Coeur Mining
CDE
$19B
$1.26M ﹤0.01%
333,840
+19,222
+6% +$55.4K
ICUI icon
1793
ICU Medical
ICUI
$4.58B
$1.26M ﹤0.01%
11,715
-7,869
-40% -$782K
AMWD
1794
DELISTED
American Woodmark
AMWD
$1.26M ﹤0.01%
12,359
+423
+4% +$39.9K
IART icon
1795
Integra LifeSciences
IART
$1.35B
$1.26M ﹤0.01%
35,421
+2,114
+6% +$84.5K
SCL icon
1796
Stepan Co
SCL
$1.48B
$1.25M ﹤0.01%
13,878
+775
+6% +$69.4K
CNS icon
1797
Cohen & Steers
CNS
$4.36B
$1.25M ﹤0.01%
16,220
+941
+6% +$67.2K
KOP icon
1798
Koppers
KOP
$857M
$1.25M ﹤0.01%
22,608
+661
+3% +$34.2K
STR
1799
DELISTED
Sitio Royalties
STR
$1.25M ﹤0.01%
50,429
+2,950
+6% +$66.4K
EFG icon
1800
iShares MSCI EAFE Growth ETF
EFG
$17.4B
$1.25M ﹤0.01%
12,000
-742
-6% -$73.9K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.